Zai Lab Limited (ZLAB) Discusses Updated Monotherapy Phase I Data for Suzhou and Outlines Next Steps in Clinical Development - Slideshow (NASDAQ:ZLAB) 2025-10-24

Group 1 - The article does not provide any specific content related to a company or industry [1]